Pfizer EBITDA 2010-2024 | PFE

Pfizer EBITDA for the quarter ending June 30, 2024 was $2.734B, a 27.42% decline year-over-year.

  • Pfizer 2023 EBITDA was 6.512B, a 83.72% decline from 2022.
  • Pfizer 2022 EBITDA was 40.008B, a 62.48% increase from 2021.
  • Pfizer 2021 EBITDA was 24.624B, a 90.43% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Pfizer EBITDA 2010-2024 | PFE

  • Pfizer 2023 EBITDA was 6.512B, a 83.72% decline from 2022.
  • Pfizer 2022 EBITDA was 40.008B, a 62.48% increase from 2021.
  • Pfizer 2021 EBITDA was 24.624B, a 90.43% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Novartis AG (NVS)$236.5B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B